Barbara Uscinska

Medicine · Health Sciences

17h-index2.0kcitations31works45.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(13), Bladder and Urothelial Cancer Treatments(9), Urinary and Genital Oncology Studies(9), Bone Tumor Diagnosis and Treatments(8), Vascular Tumors and Angiosarcomas(7)

Publications31 total

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
The Lancet·2024· 45 citedOpen Access
BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract
PLoS ONE·2019· 8 citedOpen Access
A randomised trial of chemotherapy with or without granulocyte colony-stimulating factor (G-CSF) in operable osteosarcoma
2013
A randomised trial of epirubicin and cyclophosphamide versus epirubicin and paclitaxel in the treatment of women with metastatic breast cancer
2013
A Randomised Trial of Two Chemotherapy Regimens in the Treatment of Operable Osteosarcoma (Doxorubicin-Cisplatin versus Methotrexate-Vincristine-Doxorubicin plus Doxorubicin-Cisplatin plus Bleomycin-Cyclophosphamide-Dactinomycin)
2012
A phase III study of primary chemotherapy in T2 (G3), T3 and T4a; N0 or NX; M0 transitional cell carcinoma (TCC) of the bladder
2012
A randomised comparison of ten versus three fractions of radiotherapy for palliation in patients unsuitable for radical radiotherapy or chemotherapy
2012
RECORD HAS BEEN REMOVED 12.11.03 - A randomised trial of chemotherapy with or without granulocyte colony-stimulating factor in operable osteosarcoma
2012
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
European Journal of Cancer·2011· 50 citedOpen Access
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
Annals of Oncology·2011· 201 citedOpen Access
A Phase II Trial of Continuous 5-Fluorouracil in Recurrent or Metastatic Transitional Cell Carcinoma of the Urinary Tract
Clinical Oncology·2009· 11 cited
The more it hurts, the better it works? Chemotherapy toxicity as a predictor of outcome from osteosarcoma: a report from the European Osteosarcoma Intergroup.
UCL Discovery (University College London)·2008· 1 cited
Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup
JNCI Journal of the National Cancer Institute·2007· 344 citedOpen Access
Phase III Trial of Epirubicin Plus Paclitaxel Compared With Epirubicin Plus Cyclophosphamide As First-Line Chemotherapy for Metastatic Breast Cancer: United Kingdom National Cancer Research Institute Trial AB01
Journal of Clinical Oncology·2005· 56 cited
Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study
European Journal of Cancer·2004· 60 cited
693 Does increasing dose intensity in patients with operable osteosarcoma of the extremity improve outcome? A randomised controlled trial of the European Osteosarcoma Intergroup (EOI)
European Journal of Cancer Supplements·2003· 1 cited
Chemotherapy at standard or increased dose intensity in patients with operable osteosarcoma of the extremity: A randomised controlled trial of the European Osteosarcoma Intergroup (ISRCTN 86294690).
UCL Discovery (University College London)·2003
The effect of local recurrence on survival in resected osteosarcoma
European Journal of Cancer·2001· 138 cited
Long-term survival in localised extremity osteosarcoma: Mature follow-up from two randomised trials of the European Osteosarcoma Intergroup
UCL Discovery (University College London)·2000
A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09
International Journal of Radiation Oncology*Biology*Physics·2000· 142 cited
page 1 of 2Next →

Frequent Co-authors

Pancras C.W. Hogendoorn(9), M. Nooij(8), M. van Glabbeke(7), Simon Weeden(7), Jeremy Whelan(6), Matthew R. Sydes(6), Mahesh Parmar(6), Alan Craft(5), R. J. Grimer(5), David Machin(4), Anne McTiernan(4), A. Kirkpatrick(4), Jan W. van der Eijken(3), Vivien Bramwell(3), Anne Kirkpatrick(3), Ian Lewis(3), Antonïe H.M. Taminiau(3), Gareth Griffiths(3), Sophie D. Fosså(3), Kenneth M. Grigor(3)